熱門資訊> 正文

Aptose普通股将从纳斯达克退市

2025-04-01 20:46

Aptose生物科學(APTO) 0

Aptose Biosciences (NASDAQ:APTO) announced that Nasdaq has determined to delist the common shares of the company, as of April 2, 2025.
Under the terms of the Nasdaq’s decision in this matter, the company was required to demonstrate compliance with the Exchange’s equity requirement rule on or before March 31.
APTO -37.77% premarket to $1.96.
Source: Press Release

More on Aptose Biosciences

Aptose Biosciences GAAP EPS of -$36.38
Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance
Seeking Alpha’s Quant Rating on Aptose Biosciences
Historical earnings data for Aptose Biosciences
Financial information for Aptose Biosciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。